Cancer Research Targets  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montet, X.
Right arrow Articles by Weissleder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montet, X.
Right arrow Articles by Weissleder, R.
[Cancer Research 65, 6330-6336, July 15, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Tomographic Fluorescence Mapping of Tumor Targets

Xavier Montet, Vasilis Ntziachristos, Jan Grimm and Ralph Weissleder

Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Ralph Weissleder, Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Room 5403, Charlestown, MA 02129. Phone: 617-726-8226; Fax: 617-726-5708; E-mail: weisleder{at}helix.mgh.harvard.edu.

Methods that allow robust imaging of specific molecular targets and biological processes in vivo should have widespread applications in biology and clinical medicine. Here we use a quantitative, three-dimensional fluorescence-mediated tomographic technique (FMT) that enables rapid measurements of fluorochrome-based affinity tags in live xenograft models. We validate the method by showing its sensitivity in quantitating tumor angiogenesis and therapeutic modulation using an anti–vascular endothelial growth factor antibody. Furthermore, we show the feasibility of simultaneous multichannel measurements of distinct biological phenomena such as receptor tyrosine kinase expression and angiogenesis. FMT measurements can be done serially, with short imaging times and within the same live animal. The described method should be valuable for rapidly profiling biological phenomena in vivo.




This article has been cited by other articles:


Home page
JNMHome page
M. Eisenblatter, J. Ehrchen, G. Varga, C. Sunderkotter, W. Heindel, J. Roth, C. Bremer, and A. Wall
In Vivo Optical Imaging of Cellular Inflammatory Response in Granuloma Formation Using Fluorescence-Labeled Macrophages
J. Nucl. Med., October 1, 2009; 50(10): 1676 - 1682.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Krautz-Peterson, D. Ndegwa, K. Vasquez, H. Korideck, J. Zhang, J. D. Peterson, and P. J. Skelly
Imaging schistosomes in vivo
FASEB J, August 1, 2009; 23(8): 2673 - 2680.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Korideck and J. D. Peterson
Noninvasive Quantitative Tomography of the Therapeutic Response to Dexamethasone in Ovalbumin-Induced Murine Asthma
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 882 - 889.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Zhang, Z. Yan, M. E. Arango, C. L. Painter, and K. Anderes
Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models
Clin. Cancer Res., January 1, 2009; 15(1): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. B. Lee, M. Hassan, R. Fisher, O. Chertov, V. Chernomordik, G. Kramer-Marek, A. Gandjbakhche, and J. Capala
Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging
Clin. Cancer Res., June 15, 2008; 14(12): 3840 - 3849.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. D. Luker and K. E. Luker
Optical Imaging: Current Applications and Future Directions
J. Nucl. Med., January 1, 2008; 49(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. L. Kaijzel, G. van der Pluijm, and C. W.G.M. Lowik
Whole-Body Optical Imaging in Animal Models to Assess Cancer Development and Progression
Clin. Cancer Res., June 15, 2007; 13(12): 3490 - 3497.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Nahrendorf, D. E. Sosnovik, P. Waterman, F. K. Swirski, A. N. Pande, E. Aikawa, J.-L. Figueiredo, M. J. Pittet, and R. Weissleder
Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct
Circ. Res., April 27, 2007; 100(8): 1218 - 1225.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Sosnovik, M. Nahrendorf, N. Deliolanis, M. Novikov, E. Aikawa, L. Josephson, A. Rosenzweig, R. Weissleder, and V. Ntziachristos
Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo
Circulation, March 20, 2007; 115(11): 1384 - 1391.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
X. Montet, J.-L. Figueiredo, H. Alencar, V. Ntziachristos, U. Mahmood, and R. Weissleder
Tomographic Fluorescence Imaging of Tumor Vascular Volume in Mice
Radiology, March 1, 2007; 242(3): 751 - 758.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
X. Ying and T. M. Monticello
Modern Imaging Technologies in Toxicologic Pathology: An Overview
Toxicol Pathol, December 1, 2006; 34(7): 815 - 826.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Grimm, D. G. Kirsch, S. D. Windsor, C. F. B. Kim, P. M. Santiago, V. Ntziachristos, T. Jacks, and R. Weissleder
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
PNAS, October 4, 2005; 102(40): 14404 - 14409.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.